German investigators report eye development from lab-grown brain organoids

Article

Science fiction is quickly becoming science fact as a team of German scientists found that a small, lab-grown brain cell cluster that developed fundamental eye structures.

German investigators report eye development from lab-grown brain organoids

Science fiction is quickly becoming science fact, with a team of German scientists creating small, lab-grown brain cell clusters to develop fundamental eye structures that can detect light and communicate with the brain.

According to the researchers, the sphere-shaped masses, which are categorized as “brain organoids,” are generated in a petri dish from stem cells, which can recreate the ordinary function of any cell in the body.

In the study, published in Cell Stem Cell,1 the scientists at the Heinrich-Heine-University’s Institute for Human Genetics in Düsseldorf, Germany used stem cells to grow the organoids out of the “optic cups,” which is an early stage when eyes are developing in a fetus at around five weeks old.

The researchers noted that during embryogenesis, optic vesicles develop from the diencephalon via a multistep process of organogenesis. Using induced pluripotent stem cell (iPSC)-derived human brain organoids, the team attempted to simplify the complexities and demonstrate formation of forebrain-associated bilateral optic vesicles, cellular diversity, and functionality.

The team noted that at about day 30, the brain organoids attempt to assemble optic vesicles, which develop progressively as visible structures within 60 days. These optic vesicle-containing brain organoids (OVB-organoids) constitute a developing optic vesicle’s cellular components, including primitive corneal epithelial and lens-like cells, retinal pigment epithelia, retinal progenitor cells, axon-like projections, and electrically active neuronal networks. OVB-organoids also display synapsin-1, CTIP-positive myelinated cortical neurons, and microglia. Interestingly, various light intensities could trigger photosensitive activity of OVB-organoids, and light sensitivities could be reset after transient photobleaching.

“The brain organoids have the intrinsic ability to self-organize forebrain-associated primitive sensory structures in a topographically restricted manner and can allow interorgan interaction studies within a single organoid,” the researchers wrote.

The tiny organoids are roughly 0.1 inches wide (2.54 millimeters), and the cups they are in are also minute, measuring at 0.0008 inches (0.02 millimeters) each.

However, they grow in pairs and contain some characteristics of genuine eyes, such as corneas, lenses, and primitive retinas, allowing them to “see” light.

They also reportedly develop neurons which are nerve cells that allow for communication with the central brain.

The researchers also put light on the organoids in the cup, and discovered electrical signals that traveled along their neural pathways, which indicated that some “visual information is being transmitted."

Ultimately, the work could result in the creation of lab-grown retinas for patients who have lost their vision.

Reference
1. Elke Gabriel, PhD, et al; Human brain organoids assemble functionally integrated bilateral optic vesicles; Cell Stem Cell; published Aug. 17, 2021; https://www.sciencedirect.com/science/article/pii/S1934590921002952?via%3Dihub#!

Related Content: Retina | Cataract & Refractive | Paediatrics

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
© 2025 MJH Life Sciences

All rights reserved.